Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
Author: Manny Vazquez, Senior Director Clinical Data Strategy, Veeva The number of data points collected in clinical trials has tripled…
Author: Manny Vazquez, Senior Director Clinical Data Strategy, Veeva The number of data points collected in clinical trials has tripled…
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
The growing friction between the US and China has serious consequences for the supplies of high-potency active pharmaceutical ingredients (HPAPIs),…
Parkinson’s Disease is a complex, progressive neurological condition which requires challenging, multi-modal endpoint assessment across both motor and non-motor symptoms.…
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…
“The question we must all ask ourselves is ‘What can we do to help sites overcome their challenges?’” asks John…
Artificial intelligence (AI) has become one of the most talked-about technologies of our time, but when it comes to complex…
This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and…
The global immuno-oncology (IO) market has shown remarkable expansion over the past decade, reaching an unprecedented commercial scale and driving…
This podcast explores how real-world data (RWD) fills gaps in understanding maternal and infant health, especially since pregnant individual often…